Comparison |
| Application |
General Chemistry Reagent | Immunoassay Reagent | Molecular Reagent |
| CLIA Classification |
| CLIA Non-Waived | |
| CLIA Classified |
| CLIA Non-Waived | |
| Country of Origin |
United Kingdom | United States | United States |
| For Use With |
For AU Clinical Chemistry Systems | For BD Viper Instrument | For BD Viper Instrument |
| Number of Tests |
100 Tests | 1,152 Tests | 1,152 Tests |
| Product Dating |
| McKesson Acceptable Dating: we will ship >= 30 days | McKesson Acceptable Dating: we will ship >= 30 days |
| Sample Type |
| Urine / Endocervical Swab / Vaginal Swab / Male Urethral Swab Sample | Urine / Endocervical Swab / Vaginal Swab / Male Urethral Swab Sample |
| Specialty |
General Chemistry | Immunoassay | Molecular |
| Storage Requirements |
Requires Refrigeration | | |
| Test Category |
Heart Health | Sexual Health | Sexual Health |
| Test Method |
| Amplified DNA Assay | |
| Test Name |
Homocysteine | Chlamydia Trachomatis / Neisseria Gonorrhoeae (CT / NG) | Neisseria Gonorrhoea (NG) |
| Test Type |
Cardiac | Infectious Disease | DNA Amplification / Detection |
| UNSPSC Code |
41116004 | 41116011 | 41116011 |
| Volume |
| 1,152 Tests | |
| Features and Benefits |
|
- Qualitative detection of Chlamydia trachomatis DNA in clinician-collected female endocervical and male urethral swab specimens, patient-collected vaginal swab specimens (in a clinical setting), and male and female urine specimens
|
- Qualitative detection of Neisseria gonorrhoeae DNA in clinician-collected female endocervical and male urethral swab specimens, patient-collected vaginal swab specimens (in a clinical setting), and male and female urine specimens
|
